Organic anion transporting polypeptide 2B1 expression correlates with uptake of estrone-3-sulfate and cell proliferation in estrogen receptor-positive breast cancer cells

被引:17
|
作者
Matsumoto, Jun [1 ,2 ]
Ariyoshi, Noritaka [1 ,3 ]
Sakakibara, Masahiro [4 ]
Nakanishi, Takeo [5 ]
Okubo, Yoshiyuki [4 ]
Shiina, Nobumitsu [4 ]
Fujisaki, Kaoru [4 ]
Nagashima, Takeshi [4 ]
Nakatani, Yukio [6 ]
Tamai, Ikumi [5 ]
Yamada, Harumi [2 ]
Takeda, Hiroshi [2 ]
Ishii, Itsuko [1 ,3 ]
机构
[1] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmacol, Chiba, Japan
[2] Int Univ Hlth & Welf, Dept Pharmaceut Sci, Otawara, Tochigi, Japan
[3] Chiba Univ Hosp, Div Pharm, Chiba, Japan
[4] Chiba Univ, Grad Sch Med, Dept Gen Surg, Chiba, Japan
[5] Kanazawa Univ, Fac Pharmaceut Sci, Kanazawa, Ishikawa 9201192, Japan
[6] Chiba Univ, Grad Sch Med, Dept Diagnost Pathol, Chiba, Japan
关键词
Organic anion-transporting polypeptide 2B1; Estrone-3-sulfate; Estrogen receptor; Breast cancer; Ki-67; Luminal A-like; Luminal B-Like; STEROID SULFATASE; FUNCTIONAL-ANALYSIS; PROGNOSTIC-FACTOR; CACO-2; CELLS; OATP2B1; CARCINOMA; IDENTIFICATION; PATHWAYS; THERAPY; TISSUES;
D O I
10.1016/j.dmpk.2014.10.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Estrone-3-sulfate (E1S) is thought to be a major estrogen precursor in estrogen receptor (ER)-positive breast cancer. Since E1S is a hydrophilic compound, the uptake of E1S into cancer cells is probably mediated by transporters, such as organic anion-transporting polypeptide (OATP, SLCO) family. In this study, we investigated the relationship between expression of OATP2B1 and cell proliferation in ER-positive breast cancer. Cell-based assays were carried out in MCF-7 cells both with and without overexpression of OATP2B1. Normal breast and tumor tissues were collected and used in this study. Cell proliferation, ER-mediated transcriptional activities and estradiol secretion were stimulated by addition of E1S to the culture medium of MCF-7 cells. These stimulatory effects were significantly greater in MCF-7 cells overexpressing OATP2B1 than in control cells. The expression level of SLCO2B1 mRNA was significantly correlated with histological grade, Ki-67 labelling index and mRNA expression of steroid sulfatase. The expression level of SLCO2B1 mRNA in luminal B-like cancers was higher than that in luminal A-like cancers. Uptake of E1S resulted in down-regulation of ER alpha protein and induction of Ki-67 in MCF-7 cells. The present study suggests that OATP2B1 is involved in cell proliferation by increasing the amount of estrogen in ER-positive breast cancer cells. Copyright (C) 2014, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:133 / 141
页数:9
相关论文
共 50 条
  • [41] SET-binding protein 1 (SETBP1) suppresses cell proliferation in estrogen receptor-positive breast cancer
    Ando, Yuki
    Masuda, Takaaki
    Hayashi, Naoki
    Kosai, Keisuke
    Shibuta, Shohei
    Ono, Yuya
    Taro, Tobo
    Otsu, Hajime
    Hisamatsu, Yuichi
    Yoshizumi, Tomoharu
    Mimori, Koshi
    BREAST CANCER, 2025, : 457 - 469
  • [42] Estrone-3-Sulfate Stimulates the Proliferation of T47D Breast Cancer Cells Stably Transfected With the Sodium-Dependent Organic Anion Transporter SOAT (SLC10A6)
    Karakus, Emre
    Zahner, Daniel
    Grosser, Gary
    Leidolf, Regina
    Gundogdu, Cemal
    Sanchez-Guijo, Alberto
    Wudy, Stefan A.
    Geyer, Joachim
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [43] Loss of B-cell translocation gene 2 in estrogen receptor-positive breast cancer and tamoxifen resistance
    Hayashida, T.
    Jinno, H.
    Takahashi, M.
    Kitagawa, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
  • [44] Suppression of cell proliferation and gene expression by combinatorial synergy of EGCG, resveratrol and γ-tocotrienol in estrogen receptor-positive MCF-7 breast cancer cells
    Hsieh, Tze-Chen
    Wu, Joseph M.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2008, 33 (04) : 851 - 859
  • [45] Expression levels of SF3B3 correlate with prognosis and endocrine resistance in estrogen receptor-positive breast cancer
    Goekmen-Polar, Yesim
    Neelamraju, Yaseswini
    Goswami, Chirayu P.
    Gu, Xiaoping
    Nallamothu, Gouthami
    Janga, Sarath Chandra
    Badve, Sunil
    MODERN PATHOLOGY, 2015, 28 (05) : 677 - 685
  • [46] Selective antiproliferative effect of C-2 halogenated 13α-estrones on cells expressing Organic anion-transporting polypeptide 2B1 (OATP2B1)
    Laczko-Rigo, Reka
    Bakos, Eva
    Jojart, Rebeka
    Tomboly, Csaba
    Mernyak, Erzsebet
    Ozvegy-Laczka, Csilla
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2021, 429
  • [47] Interplay between the Nuclear Receptor Pregnane X Receptor and the Uptake Transporter Organic Anion Transporter Polypeptide 1A2 Selectively Enhances Estrogen Effects in Breast Cancer
    Schwabedissen, Henriette E. Meyer Zu
    Tirona, Rommel G.
    Yip, Cindy S.
    Ho, Richard H.
    Kim, Richard B.
    CANCER RESEARCH, 2008, 68 (22) : 9338 - 9347
  • [48] Association between farnesoid X receptor expression and cell proliferation in estrogen receptor-positive, luminal-like breast cancer from postmenopausal patients
    Journe, Fabrice
    Durbecq, Virginie
    Rouas, Ghizlane
    Chaboteaux, Carole
    Laurent, Guy
    Nonclercq, Denis
    Sotiriou, Christos
    Body, Jean-Jacques
    Larsimont, Denis
    ACTA CLINICA BELGICA, 2008, 63 (02): : 127 - 127
  • [49] Association between farnesoid X receptor expression and cell proliferation in estrogen receptor-positive luminal-like breast cancer from postmenopausal patients
    Journe, Fabrice
    Durbecq, Virginie
    Chaboteaux, Carole
    Rouas, Ghizlane
    Laurent, Guy
    Nonclercq, Denis
    Sotiriou, Christos
    Body, Jean-Jacques
    Larsimont, Denis
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 115 (03) : 523 - 535
  • [50] Association between farnesoid X receptor expression and cell proliferation in estrogen receptor-positive luminal-like breast cancer from postmenopausal patients
    Fabrice Journe
    Virginie Durbecq
    Carole Chaboteaux
    Ghizlane Rouas
    Guy Laurent
    Denis Nonclercq
    Christos Sotiriou
    Jean-Jacques Body
    Denis Larsimont
    Breast Cancer Research and Treatment, 2009, 115 : 523 - 535